Timothy M. Hospedales is a Professor of Artificial Intelligence at the Institute of Perception, Action and Behaviour within the School of Informatics at the University of Edinburgh . He also serves as VP AI and Head of Samsung AI Research Centre Europe . His research focuses on efficient and robust AI , emphasizing meta-learning , lifelong transfer-learning , and domain adaptation in both probabilistic and deep learning frameworks. Applications span computer vision , vision and language , reinforcement learning for robotics , and finance . Professor at University of Edinburgh (2020–present) ELLIS Fellow (2021) Head of Samsung AI Research Europe (2020–present) Founding Director of Applied Machine Learning Lab at QMUL (2012–2016) His work includes pioneering contributions to meta-learning , few-shot learning , and self-supervised methods , with notable awards such as the Best Paper Prize at ICML AutoML 2018 and Best Student Paper at ICPR 2018 . He has co-authored 15+ recent papers on topics like Vision-Language Models , Medical AI Fairness , and Diffusion Model Optimization . He served as Program Co-Chair for BMVC 2018 and AAAI 2022 , and authored a book on Visual Adaptation in the Deep Learning Era (2022). Co-Chair, BMVC 2018 Guest Editor, IET CV Special Issue (2016) Keynote Speaker at TASK-CV Workshop (ECCV 2016) Special Issue on Fewer Labels (IEEE PAMI 2020) His leadership extends to organizing workshops like the Learning-to-Learn Workshop at ICLR 2021 , Meta-Learning Workshop at NeurIPS 2020 , and Domain Generalisation Workshop at ICLR 2023 . Current projects include Meta-Omnium (CVPR 2023) for general-purpose meta-learning and MetaAudio (ICANN 2022) for few-shot audio classification benchmarks.
جستجوی استاد راهنمای دانشگاهی
برای مسیر پژوهشیتان، استاد راهنما، استاد دانشگاه و پژوهشگر مناسب را پیدا کنید و با آنها ارتباط بگیرید.
نمایش ۱-۱۵ از ۱۰۱ استاد راهنما
اطلاعات پروفایلها از صفحات عمومی دانشگاهها گرفته شده و ممکن است بهروز نباشد.
Thomas Perlmann is a Professor in Molecular Developmental Biology at the Karolinska Institutet , leading research at the Department of Cell and Molecular Biology and serving as Director of the Stockholm Branch of the Ludwig Institute for Cancer Research. He also holds the position of Secretary General of the Nobel Assembly and Nobel Committee for Physiology or Medicine since 2016. Ph.D. , Karolinska Institutet, 1991 M.Sc. , Stockholm University, 1987 Research Interests : The Perlmann lab investigates the specification and maintenance of dopamine neurons in the central nervous system, with a focus on transcriptional regulation , signaling pathways , and regenerative medicine applications for Parkinson’s disease and other neurodegenerative disorders. His work bridges developmental biology and neuroscience , emphasizing the role of transcription factors in neuronal identity and function. Recent Research Trends : Perlmann’s recent publications highlight the use of single-cell RNA sequencing to dissect dopamine neuron heterogeneity , epigenetic regulation during development, and transcriptomic changes in Parkinson’s disease models. His studies increasingly leverage multiomics and bioinformatics to map neuronal lineage trajectories and gene expression dynamics. Scientific Awards : Royal Medal by HM the King (2025) Nicholson Lecturer, Rockefeller University (2011) Göran Gustafsson Prize in Molecular Biology (1999) Eric K. Fernström Young Investigator Prize (1997) Advising & Collaborations : While no student names are explicitly listed, Perlmann collaborates extensively with researchers such as Malin Parmar , Agnete Kirkeby , and Per Svenningsson on projects related to neuronal development and cell therapy . His lab receives funding from institutions like the Ludwig Institute for Cancer Research . Labs & Teams : The Perlmann Lab at Karolinska Institutet includes researchers like Linda Gillberg , Laura Lahti , and Behzad Yaghmaeian Salmani , who work on mouse models , single-cell transcriptomics , and bioinformatics to study dopamine neuron biology.
Douglas Lobnerمشاهده پروفایل
استاد پژوهش
Dr. Douglas Lobner is a Research Professor in the Department of Biomedical Sciences at Marquette University, College of Health Sciences. His research focuses on neurodegenerative disease mechanisms, environmental toxin interactions, and dental material toxicity. He investigates how environmental factors like mercury, pesticides, and BMAA interact with genetic predispositions to cause neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS, particularly through the cystine/glutamate transporter (system xc-). His work also explores dental pulp capping materials, emphasizing growth factor-enhanced repair mechanisms and system xc- regulation to prevent root canal procedures. Key collaborations involve studies on glutamate signaling, neurotoxicant synergy, and drug-induced neuroplasticity. Published research includes over 14 studies from 2009–2014, emphasizing system xc- regulation by growth factors, neurotoxin synergies (e.g., methylmercury and BMAA), and dental material toxicity mitigation strategies. His lab contributes to the Neuroscience Collaboratory and Integrative Neuroscience Research Center at Marquette.
Michael Qizhe Shieh is an Assistant Professor in the Department of Computer Science at the National University of Singapore (NUS), affiliated with the Tree and Rock AI Lab (TRAIL). He holds a PhD and Master's from Carnegie Mellon University (Machine Learning and Language Technologies) and a Bachelor's from Shanghai Jiao Tong University's ACM Class. His research focuses on Large Language Models, Deep Learning, and Natural Language Processing, with notable contributions to semi-supervised learning techniques like Noisy Student and UDA, and the RACE benchmark for reading comprehension. Education: PhD in Machine Learning, Carnegie Mellon University (2020) Master's in Language Technologies, Carnegie Mellon University (2018) Bachelor's in Computer Science, Shanghai Jiao Tong University (2016) His research explores robustness, safety, and scalability of AI systems. He has served as Area Chair for top conferences like NeurIPS, ICML, and ICLR. Current research directions include adversarial robustness, LLM self-evaluation, and alignment mechanisms. His lab, TRAIL, emphasizes foundational AI research. Selected contributions include: Developing UDA and Noisy Student techniques for semi-supervised learning Creating the RACE benchmark for exam-based reading comprehension Advancing methods for LLM safety and adversarial defense Prospective students are encouraged to apply to NUS's PhD program for collaborative research opportunities.
Charles L. White is Professor of Pathology at UT Southwestern Medical Center, where he holds the Nancy R. McCune Distinguished Chair in Alzheimer Disease Research. He has served as Director of Neuropathology at UT Southwestern since completing his residency and fellowship training in anatomic pathology and neuropathology at Johns Hopkins in 1983. Dr. White also directs the Neuropathology Core of the UT Southwestern Alzheimer Disease Research Center (established 1988) and the Winspear Family Special Center for Research on the Neuropathology of Alzheimer's Disease (established 2002). Dr. White completed his medical and pathology training at Johns Hopkins University, establishing a career focused on neurodegenerative brain disorders. His educational background forms the foundation for his dual expertise in clinical neuropathology and research investigation. Dr. White's research spans multiple critical areas of neuropathology: Pathological mechanisms of Alzheimer's disease and related dementias Tau protein aggregation and propagation across neurodegenerative conditions Diagnostic criteria and staging systems for various neuropathologies Genetic and molecular underpinnings of frontotemporal lobar degeneration Chronic traumatic encephalopathy and its relationship to other neurodegenerative conditions Development of artificial intelligence approaches for neuropathological assessment Analysis of Dr. White's extensive publication record reveals a consistent focus on defining and characterizing neurodegenerative disease processes through rigorous pathological examination. His work frequently addresses diagnostic criteria, disease classification systems, and the molecular mechanisms underlying various neurodegenerative conditions. There is particular emphasis on tau pathology across multiple disease states, including Alzheimer's disease, primary age-related tauopathy (PART), and chronic traumatic encephalopathy (CTE). His research often involves large collaborative efforts with multiple institutions, reflecting the complex, multidisciplinary nature of modern neuropathological research. Dr. White has received significant recognition for his contributions to the field: Award for Meritorious Contributions to Neuropathology from the American Association of Neuropathologists (2020) Nancy R. McCune Distinguished Chair in Alzheimer Disease Research As an educator and mentor, Dr. White serves as Training Director for the Neuropathology Fellowship program at UT Southwestern, an ACGME-accredited, 2-year training program. Twenty-two trainees have completed the program and become board certified by the American Board of Pathology in the subspecialty of Neuropathology. He has held significant leadership positions including past president of the American Association of Neuropathologists, the national professional organization for neuropathologists in the US. His mentorship extends to numerous research collaborations where he guides junior investigators in neuropathological research methods and interpretation. Dr. White directs multiple research centers including the Neuropathology Core of the UT Southwestern Alzheimer Disease Research Center and the Winspear Family Special Center for Research on the Neuropathology of Alzheimer's Disease. His laboratory work focuses on understanding the pathological mechanisms of neurodegenerative diseases, particularly those involving protein misfolding and aggregation. His team employs advanced techniques including immunohistochemistry, molecular pathology, and increasingly, artificial intelligence approaches to analyze neuropathological specimens.
- Neuropharmacology
- Neuroscience
- Dopamine Neurons
- +۵ مورد دیگر
Louis-Éric Trudeau is a Full Professor in the Department of Pharmacology and Physiology and Department of Neuroscience at the University of Montreal's Faculty of Medicine. He directs the Neural Signaling and Circuitry Research Group (SNC) and is a member of the Interdisciplinary Center for Brain and Learning Research (CIRCA). His laboratory focuses on understanding the fundamental mechanisms of dopamine neuron function and their role in Parkinson's disease. Education: BSc (Honors) in Psychology from Concordia University (1990) DEA in Neuroscience from University of Paris (1991) PhD in Neuroscience from University of Montreal (1994) Postdoctoral training at Iowa State University (1994-1996) Dr. Trudeau's research primarily investigates dopamine neurotransmission, with a focus on understanding how dopamine neurons function normally and why they degenerate in Parkinson's disease. His work spans cellular and molecular neuroscience, exploring mechanisms of neurotransmitter release, axonal arborization, mitochondrial function, and the role of the immune system in neurodegeneration. His laboratory employs a wide range of techniques including electrophysiology, electrochemistry, fluorescence imaging, confocal microscopy, and molecular biology approaches using normal and genetically modified mouse brain preparations. Analysis of Dr. Trudeau's recent publications reveals a strong focus on Parkinson's disease mechanisms, particularly examining the selective vulnerability of dopamine neurons, the role of mitochondrial function, immune system involvement, and neurotransmitter co-transmission. His work increasingly integrates immunological perspectives with traditional neuroscience approaches to understand Parkinson's disease pathogenesis. Dr. Trudeau has successfully secured substantial research funding from multiple sources including the Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council (NSERC), Parkinson Society Canada, Brain Canada Foundation, and the Michael J. Fox Foundation. His current projects span from basic cellular neuroscience to translational research aimed at developing new therapeutic strategies for Parkinson's disease. As an educator, Dr. Trudeau supervises numerous graduate students and postdoctoral fellows, teaching courses in cellular and molecular neuroscience, neuropharmacology, and the nervous system. His laboratory provides training in advanced neuroscience techniques to the next generation of researchers.
Ahmad Lotfi is a Professor of Computational Intelligence and Head of Department of Computer Science at Nottingham Trent University , with a Visiting Professor role at Tokyo Metropolitan University . He leads the Computational Intelligence and Applications (CIA) research group and has supervised over 30 PhD students to completion. PhD in Learning Fuzzy Systems (University of Queensland, 1995) MTech in Control Systems (Indian Institute of Technology, India) BSc in Control Systems (Isfahan University of Technology, Iran) His research spans computational intelligence , ambient intelligence , robotics , and machine learning , with applications in dementia monitoring , smart environments , and healthcare technology . Recent work focuses on using thermal sensor arrays for privacy-preserving human activity analysis. He has secured funding from Innovate UK , EPSRC , The Royal Society , and Horizon 2020 , with projects like iCarer (assistive living), SmartBerry (agricultural AI), and BigSpark (financial data augmentation). His 15 most recent articles demonstrate expertise in Wi-Fi-based activity recognition , EEG fall detection , and thermal sensor fusion . Senior Member IEEE Member of British Computer Society (MBCS) Editorial roles in Soft Computing and Journal of Ambient Intelligence and Smart Environments He has served as Program Chair for conferences like PETRA and ICCRT , and as Keynote Speaker at PETRA 2023 . His 28+ years of academic leadership include organizing UKCI and UKRAS conferences.
Prof. Dr. Donato Di Monte serves as Group Leader at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, Germany. His laboratory focuses on Parkinson's disease (PD) pathogenesis with emphasis on alpha-synuclein toxicity mechanisms and neurodegenerative processes. Research interests span: Experimental models of PD pathology including viral vector-induced alpha-synuclein overexpression in dorsal motor nucleus of vagus nerve (DMnX) Advanced histological and molecular techniques such as fluorescent in situ hybridization for alpha-synuclein mRNA detection Key mechanisms: mitochondrial failure, protein degradation impairment, microglial activation, and neuron-to-neuron protein transfer Disease risk factors including aging, genetic variants, and environmental exposures Therapeutic strategies: RNA silencing, immunotherapy, and regenerative cell therapy The group bridges PD research with other neurodegenerative disorders to investigate selective neuronal vulnerability and pathological comorbidity. Their work demonstrates how caudo-rostral alpha-synuclein spreading (e.g., from medulla oblongata to pons) triggers microglial activation in aging brains and contributes to neurodegeneration in vulnerable regions like locus coeruleus and substantia nigra. Experimental highlights include: AAV-mediated alpha-synuclein targeting in vagus nerve projections RNA interference showing reduced alpha-synuclein expression in substantia nigra neurons Visualization of alpha-synuclein accumulation in locus coeruleus axons following protein spreading
Dr. Natalia Rodríguez-Muela is a Junior Group Leader at the Center for Regenerative Therapies Dresden (CRTD) , affiliated with the German Center for Neurodegenerative Diseases (DZNE) and the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) in Dresden, Germany. Studied selective motor neuron death in neurodegenerative diseases Developed human iPSC-based models to analyze SMN protein heterogeneity Focus on proteostasis failure and cell/non-cell autonomous factors Research interests revolve around molecular mechanisms of neuronal vulnerability , particularly in amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) . Her work explores how genetic backgrounds, cellular diversity, and autophagy-lysosome dysregulation contribute to disease progression. Scientific achievements include: ERC Starting Grant (2019-2024) Muscular Dystrophy Association Development Grant (2016-2019) Keystone Symposia scholarship (2016) The group utilizes hiPSC models , transgenic animals , and single-cell genomics to investigate neuronal protection mechanisms. Funding comes from European and German institutions.
Ramesh Chandraمشاهده پروفایل
استادیار
- Addiction
- Depression
- Optogenetics
- +۷ مورد دیگر
Ramesh Chandra, PhD, is an Assistant Professor in the Department of Neurobiology at the University of Maryland, Baltimore , and serves as Director of the UMB Virus Vector Core (VVC) . His research focuses on molecular and behavioral mechanisms in addiction and depression, particularly through neuronal subtypes in the nucleus accumbens. Education: B.S. in Biology (1999), M.S. in Zoology (2001), PhD in Zoology (2010) from Indian institutions Research spans addiction, depression, optogenetics, striatum biology, and epigenetic regulation , with a strong emphasis on mitochondrial dynamics in neuronal subtypes. His work includes cell-specific transcriptomics, gene therapy vector optimization, and pharmacological interventions in rodent models. Scientific awards include the NARSAD Young Investigator Award and prior research fellowships from the Council of Scientific and Industrial Research, India. He has contributed to mitochondrial gene regulation , neuronal subtype plasticity , and gene therapy core leadership at UMB.
- Cardiac Arrest
- Stroke
- Traumatic Brain Injury
- +۷ مورد دیگر
Robert E. Rosenthal, MD, is a Professor of Emergency Medicine and Anesthesiology at the University of Maryland, Baltimore. He holds administrative appointments as Assistant Provost for Research Compliance and Chair of the Institutional Review Board, overseeing ethical review for 2,000+ human research protocols. Clinically, he directs the Hyperbaric Medicine program at the R Adams Cowley Shock Trauma Center, managing emergent cases like carbon monoxide poisoning and decompression sickness. Education: Yale University, BA Chemistry (1975) New York University School of Medicine, MD (1979) George Washington University, Residency in Internal Medicine (1979–1982) Research Focus: Dr. Rosenthal investigates neuroprotection after cardiac arrest, developing large-animal models to study ischemia-reperfusion injury. His work demonstrates hyperoxia's detrimental effects post-resuscitation and pioneers oximetry-guided oxygen titration protocols. Additional research explores hypobaria's impact on traumatic brain injury and hyperbaric oxygen therapy. Publication Trends: His 15 most recent articles (1987–2010) focus on oxidative stress, mitochondrial dysfunction, and neuroprotective strategies in cerebral ischemia. Key themes include hyperoxia/hypoxia balance, metabolic rescue agents (e.g., acetyl-L-carnitine), and hyperbaric oxygen applications. Grants: US Air Force FA8650-15-2-6D21 (2014–2017): Co-Investigator studying hypobaria effects on brain injury after polytrauma NIH R01 NS091099-01A1 (2015–2020): Co-PI investigating optimal oxygenation and gene expression post-cardiac arrest Clinical & Collaborations: Leads a 24/7 hyperbaric medicine team at Shock Trauma and collaborates extensively with Dr. Gary Fiskum on ischemia-reperfusion mechanisms.
Anna Orrمشاهده پروفایل
استادیار
Anna Orr is an Assistant Professor at Weill Cornell Medicine's Graduate School of Medical Sciences and holds the Nan and Stephen Swid Endowed Professorship of Frontotemporal Dementia Research. The Orr lab investigates glial-neuronal interactions with a focus on astrocytes and mitochondria as therapeutic targets for neurocognitive impairments in FTD, AD, and related disorders. Emory University (PhD in Neuroscience) Gladstone Institutes/UCSF (Postdoctoral Research Fellow) Research interests include: Mechanisms of glial-neuronal interactions in neurodegenerative diseases Mitochondrial reactive oxygen species (ROS) production and regulation Sex-specific cognitive modulation via astrocytic receptor signaling Antiviral pathway disruptions in dementia Translational approaches using transgenic models and omic technologies Therapeutic targeting of neuroimmune and redox pathways Notable article trends: Sex-dimorphic effects of astrocytic receptors on memory Neuroimmune signaling in nucleocytoplasmic disruptions TDP-43 pathology in astrocyte antiviral pathways Mitochondrial ROS contributions to dementia pathology Multi-omics approaches to identify therapeutic targets Scientific awards: 2021 Outstanding Neuroscience Teaching and Mentoring Award 2021 Nan and Stephen Swid Endowed Professorship Accelerating Drug Discovery for FTD Grant (AFTD/ADDF) Lab members include graduate students Daniel Barnett (Glial biology), Laraib Ijaz (Gliopathophysiology), Caroline Booraem (Oxidative stress), Evelyn Hardin (Neuroimmune interactions), Alicia Whye (GPCR roles in memory), and postdoctoral researchers Minwoo Wendy Jang and Pedro Negri Bernardino. The lab is part of the Brain and Mind Research Institute and collaborates with the Appel Alzheimer's Disease Research Institute.
William Hortonمشاهده پروفایل
دانشگاهی
- Circadian Rhythms
- Drug Abuse
- Nicotine Addiction
- +۷ مورد دیگر
William Horton is an Assistant Teaching Professor at the Biobehavioral Health Department within Penn State University's College of Health and Human Development . His research focuses on the intersection of circadian rhythms and substance abuse, particularly nicotine addiction, examining how molecular and genetic changes influence behavior and vice versa. Education Ph.D. in Integrative Physiology and Neuroscience from University of Colorado - Boulder B.S. in Zoology from Michigan State University Research Interests encompass: Molecular mechanisms linking circadian rhythms and addiction Genetic influences on drug-seeking behavior Neuroimaging of substance exposure effects Environmental factors (light, sleep) in maternal and child health Stress interactions with opioid and nicotine addiction Translational preclinical models of addiction and aging Selected Publications demonstrate expertise in neurogenetics, sleep disorders, and addiction science, with recent work on miRNA regulation in stress models (2024), opioid neuroimaging (2023), and cross-species transcriptomic studies (2019).
Dmitry Velmeshevمشاهده پروفایل
استادیار
Dmitry Velmeshev is an Assistant Professor in the Departments of Neurobiology and Biomedical Engineering at Duke University. He focuses on understanding human brain development and neurodevelopmental diseases at the single-cell level, particularly autism. His work integrates genomics, proteomics, and molecular biology to dissect genetic programs and neuronal circuitry. Ph.D., University of Miami (2016) Research interests include neurodevelopmental disorders, single-cell genomics, and molecular mechanisms of autism. Recent studies explore SARS-CoV-2 tropism for astrocytes, LRRK2 kinase activity in Parkinson’s disease, and glial roles in neurodegeneration. His lab employs transcriptomic and proteomic approaches to identify phenotypic modifiers in disease models. Selected publications highlight applications of single-cell analysis in autism and multiple sclerosis, proteomic mapping in neurodevelopmental models, and inflammation in neurodegenerative disease. No scientific awards or student advisees are mentioned in the provided text. He teaches courses such as NEUROSCI 494, NEUROSCI 493, NEUROBIO 790S, NEUROBIO 735, CMB 710F, and CMB 710E at Duke University.
Harish Vasudevanمشاهده پروفایل
پزشک-پژوهشگر
Dr. Harish Vasudevan is a physician scientist at the University of California San Francisco (UCSF), holding joint appointments in the Departments of Radiation Oncology and Neurological Surgery. His research focuses on neurofibromatosis and nervous system tumors, particularly investigating oncogenic growth factor signaling through receptor tyrosine kinases and the Ras pathway to identify novel therapeutic strategies. Education: PhD in Medicine/Neuroscience from Mount Sinai School of Medicine (2017), MD, and BS in Biology from Caltech (2009) Research highlights include molecular profiling of melanoma brain metastases, epigenetic reprogramming in schwannomas, and spatial genomic analysis of meningiomas. Current projects supported by the Department of Defense and Children's Tumor Foundation aim to clarify Ras GAP specificity and develop NF1 reconstitution therapies. Selected Awards: SNO Adult Basic Research Abstract Award (2017), Roentgen Resident/Fellow Research Award (2022-2025), Francis Collins Scholar Award (2022) Dr. Vasudevan's collaborative work spans brain metastasis atlases, radiation-immunotherapy synergy, and neurogenetic imaging-genomics correlations. His publications demonstrate expertise in genomic analysis, spatial transcriptomics, and clinical outcomes research.